Myriad Genetics EVP granted 257,731 RSUs

EVP, Commercial Vishal Sikri received a large time-based RSU award that vests over three years under MYGN’s 2026 equity incentive plan.

Rhea-AI Filing Summary

MYRIAD GENETICS INC (symbol: MYGN) is the issuer of record for a Form 4 filing submitted to the SEC. Sikri Vishal reported acquisition or exercise transactions in this Form 4 filing.

MYRIAD GENETICS INC (MYGN) reported that EVP, Commercial Vishal Sikri received a grant of 257,731 time-based restricted stock units of common stock on September 16, 2026. The award was made under the company’s 2026 Equity Incentive Plan and vests in three equal annual installments.

Each restricted stock unit represents a contingent right to receive one share of common stock. Following this grant, Sikri holds 351,224 shares of MYGN common stock directly. No Rule 10b5-1 trading plan is reported for this award.

Insider Trade Summary

Grant/Award: 257,731 shares

Grant/Award 1 txn

Insider Sikri Vishal

Role EVP, Commercial

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1	257,731	$0.00	$0.00

Holdings After Transaction: Common Stock — 351,224 shares (Direct)

Footnotes (1)

1. F1. Consists of time-based restricted stock units granted pursuant to the Issuer's 2026 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date.

Key Figures

Restricted stock units granted: 257,731 units Grant price per share: $0.00 Shares held after transaction: 351,224 shares +1 more

4 metrics

Restricted stock units granted 257,731 units Time-based RSUs granted on September 16, 2026

Grant price per share $0.00 RSU award granted for no cash consideration

Shares held after transaction 351,224 shares Direct ownership by Vishal Sikri following the RSU grant

Vesting schedule 3 equal annual installments Beginning on the first anniversary of the September 16, 2026 grant date

Key Terms

restricted stock units, contingent right, vests, Equity Incentive Plan

4 terms

restricted stock units financial

"Consists of time-based restricted stock units granted pursuant to the Issuer's 2026"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

contingent right financial

"Each restricted stock unit represents a contingent right to receive one share"

vests financial

"and vests in three equal annual installments beginning on the first anniversary"

Equity Incentive Plan financial

"pursuant to the Issuer's 2026 Employee, Director and Consultant Equity Incentive Plan"

An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What equity award did MYGN grant to EVP, Commercial Vishal Sikri?

MYRIAD GENETICS INC granted 257,731 time-based restricted stock units of common stock to EVP, Commercial Vishal Sikri on September 16, 2026, as a compensation-related award under the company’s 2026 Employee, Director and Consultant Equity Incentive Plan.

How do Vishal Sikri’s MYGN restricted stock units vest?

The 257,731 restricted stock units granted to Vishal Sikri vest in three equal annual installments, beginning on the first anniversary of the September 16, 2026 grant date. Each vested unit entitles him to receive one share of MYRIAD GENETICS INC common stock.

How many MYGN shares does Vishal Sikri hold after this Form 4 transaction?

After the reported grant, EVP, Commercial Vishal Sikri directly holds 351,224 shares of MYRIAD GENETICS INC common stock. This total includes the newly granted restricted stock units, which are subject to time-based vesting over three years.

Was the MYGN equity grant to Vishal Sikri made under a Rule 10b5-1 plan?

No. The filing indicates the Rule 10b5-1 checkbox is not marked for this Form 4, meaning no Rule 10b5-1 trading plan is reported in connection with the September 16, 2026 restricted stock unit grant.

What plan governs the restricted stock units granted to MYGN’s EVP, Commercial?

The 257,731 restricted stock units granted to EVP, Commercial Vishal Sikri were issued under MYRIAD GENETICS INC’s 2026 Employee, Director and Consultant Equity Incentive Plan, which provides for equity-based compensation awards to employees, directors and consultants.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/17/2026 - 04:35 PM Accepted by SEC EDGAR 09/17/2026 - 04:34 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sikri Vishal

(Last) (First) (Middle)

322 NORTH 2200 WEST

(Street)

SALT LAKE CITY UTAH 84116

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MYRIAD GENETICS INC [ MYGN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Commercial

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/16/2026		A		257,731(1)	A	$0	351,224	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Consists of time-based restricted stock units granted pursuant to the Issuer's 2026 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date.

Remarks:

	By: Justin Hunter For: Vishal Sikri	09/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)